UPDATE: Roth Capital Upgrades Seelos Therapeutics (SEEL) to Buy
Tweet Send to a Friend
(Updated - September 27, 2021 8:41 AM EDT)
Roth Capital analyst Jonathan Aschoff upgraded Seelos Therapeutics (NASDAQ: SEEL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Jonathan Aschoff upgraded Seelos Therapeutics (NASDAQ: SEEL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
